Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Johnson & Johnson gains CE mark approval for catheter capable of radiofrequency, PFA ablation
A new catheter from Johnson & Johnson MedTech is now approved to treat cardiac arrhythmias in Europe. Could FDA approval be on the horizon?
Robotic mitral repair compares favorably to surgery—but some concerns remain
Robotic-assisted mitral valve repair is associated with short-term outcomes comparable to conventional surgery, according to a new analysis of more than 40,000 patients. Robotic treatment also helps patients spend less time in the hospital, but the costs are much higher.
FDA has now cleared more than 1,000 AI models, including many in cardiology
Cardiology is the medical speciality with the second most FDA clearances overall.
Altered brain structure may play a role in eating disorders, MRI data suggest
Experts recently uncovered evidence suggesting behaviors such as undereating, binging and purging could be owed to anatomical alterations in parts of the brain.
Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications
Johnson & Johnson MedTech's Varipulse PFA system has been linked to multiple reports of "neurovascular events" in patients. The company hopes to share more information in the days ahead.

Occlutech gains FDA approval for occluder device for atrial septal defects

According to CEO Sabine Bois, a veteran of the medical device industry, this approval represents a "significant leap forward" in the company's commitment to heart patients.

January 8, 2024

Self-expanding TAVR system with new sealing cuff linked to high success rate, favorable outcomes

The valve, designed with a new-look sealing cuff for limiting paravalvular regurgitation, gained FDA approval in January 2023.

January 8, 2024

Stephanie Golab, MD, NYU Grossman School of Medicine, explains statistics on heart transplant outcomes in older adults

It may be time to revisit patient selection protocols for heart transplants

In a new video interview, Stephanie Golab, MD, examines the latest data on heart transplant outcomes in older adults.

January 8, 2024

AI artificial intelligence stethoscope doctor

AI models for predicting heart failure still far from perfect

Advanced AI models can evaluate a patient's heart failure risk using 12-lead ECG data—but there is still some room for improvement.

January 5, 2024

The Medtronic Micra leadless pacemaker implanted inside the heart. It is about the size of a large vitamin pill and is implanted using a catheter.

Medtronic receives CE mark approval for next-generation leadless pacemakers

The two devices, already approved by the FDA, were designed with batteries expected to last more than 15 years.

January 5, 2024

Fraud charges against cardiologist dismissed after 8-year legal battle

The veteran interventional cardiologist was initially sentenced to five years in prison for healthcare fraud. After multiple appeals and some significant updates, however, he was granted a new trial.

January 5, 2024

Football linked to damage of white matter in brain, a marker of dementia

Researchers discovered potential brain damage in both college and professional players.

January 4, 2024

Eli Lilly and Company launches online marketplace with home delivery to combat ‘complex’ healthcare system

The news comes as more and more medications, including Lilly's own tirzepatide, are being used to treat both obesity and diabetes.

January 4, 2024

Clinical

Johnson & Johnson gains CE mark approval for catheter capable of radiofrequency, PFA ablation

Robotic mitral repair compares favorably to surgery—but some concerns remain

FDA has now cleared more than 1,000 AI models, including many in cardiology

Altered brain structure may play a role in eating disorders, MRI data suggest

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications